Our publication

Here are all published scientific articles from the Icelandic Heart Associations.

Contact us

We are writing it as we speak!

We are working on putting our publications online in English. Please check back soon for some more exciting content.

Below you will find our Scientific articles

Scientific articles

Nr.2/21

Effect of the StuI polymorphism in the LDL receptor gene (Ala 370 to Thr) on lipid levels in healthy individuals

V. Gudnason, D. Patel, X-M. Sun, S. Humphries, A.K. Soutar, B.L. Knight. Clinical Genetics 1995:47;68-74.

Opna >

Nr.4/21

The molecular genetics of pediatric lipid disorders: recent progress and future research directions

Humphries SE, Mailly F, Gudnason V, Talmund P. Pediatr Res. 1993 Oct;34(4):403-415

Opna >

Nr.6/21

The molecular genetics of paedriatic lipid disorders: Recent progress and future research directions

Humphries SE, Mailly, Gudnason V, Talmud P. Pediatric research 1993 34 (4):403-415

Opna >

Nr.8/21

Identification of recurrent and novel mutations in exon 4 of the ldl receptor gene in patients with familial Hypercholesterolemia in the United Kingdom

Gudnason V, King-Underwood L, Seed M, Sun X-M, Soutar AK, Humphries SE. Arteriosclerosis and Thrombosis 1993;13:56-63.

Opna >

Nr.9/21

Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of hdl and apo A-I

Sigurdsson Jr. G, Gudnason V, Sigurdsson G, Humphries SE. Arteriosclerosis and Thrombosis 1992;12:1017-1022.

Opna >

Nr.10/21

Identification of common genetic polymorphism that determine plasma levels of apo A-I and HDL.

Humphries S, Gudnason V, Paul-hayase H, Saha N, Rosseneu M. 1992 NATO advanced workshop, Limone Italy. Springer-Verlag Berlin Vol H73 pp183-194

 

Opna >

Nr.11/21

Characterization of deletions in the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom

Sun X-M, Webb JC, Gudnason V, Humphries S, Seed M, Thompson GR, Knight BL, Soutar AK. Arteriosclerosis and Thrombosis 1992;12:762-770.

Opna >

Nr.12/21

A PCR based method to create a specific mutation to use as a reference for oligomelting

V.Gudnason and S.Humphries. Clinical Chemistry 1991.

Opna >

Nr.13/21

Identification of the 664 proline to leucine mutation in the low density lipoprotein receptor in four unreleated patients with familial hypercholesterolaemia in the UK

Linda King-Underwood, Vilmundur Gudnason, Steve Humphries, Mary Seed, Dilip Patel, Brian Knight and Anne Soutar. Clinical Genetics 1991;40:17-28.

Opna >

Nr.14/21

Genetic effects on blood cholesterol

Gunnar Sigurdsson, Vilmundur Gudnason.  Icelandic Medical Journal 1990; 76:60-72.

Nr.15/21

Use of the Polymerase Chain Reaction to search for a mutation in the Apolipoprotein gene in the Icelandic population

Vilmundur Gudnason, Gunnar Sigurdsson, Steve Humphries. Icelandic Medical Journal 1990; 76:

Opna >

Nr.16/21

Polymorphism of the c-Ha-ras-1 proto-oncogene in Icelandic breast cancer patients

Rosa B. Barkardottir, Oskar Th. Johannsson, Adalgeir Arason, Vilmundur Gudnason, Valgardur Egilsson. Int J Cancer 1989; 44: 251-255.

Opna >

Nr.17/21

A study of familial hypercholesterolaemia in Iceland using RFLPs

Rohan Taylor, Jonathan Bryant, Vilmundur Gudnason, Gunnar Sigurdsson, Steve Humphries. J Med Genet 1989;26:494-498.

Opna >

Nr.18/21

Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresis

Peter J. Wirth, Valgardur Egilsson, Vilmundur Gudnason, Sigurdur Ingvarsson, Snorri S. Thorgeirsson. Breast Cancer Research and Treatment 1987; 10:177-89.

 

 

Opna >

Nr.19/21

Catabolic repressive effects of 5-Thio-D-glucose on Saccharomyces cervisiae

Valgardur Egilsson, Vilmundur Gudnason, Adalbjorg Jonasdottir, Sigurdur Ingvarsson, Valgerdur Andresdottir. J Gen Microbiol 1986;132:3309-13.

Opna >

Nr.21/21

Isoensyme pattern and subcellular localization of hexokinases in human breast cancer and nonpathological breast tissue

Vilmundur Gudnason, Sigurdur Ingvarsson, Adalbjorg Jonasdottir, Valgerdur A­ndres­dottir, Valgardur Egilsson. Int. J. Cancer 1984;34:63-6.

Opna >

Any questions?Contact us

If you have any questions, comments or concerns, don’t hesitate to contact us. We will get back to you as soon as possible.

Staðsetning Hjartaverndar

Location

Holtasmári 1, 2. floor 201 Kópavogur, Iceland SSN.: 010104-0809

See on map

Hafa samband við hjartavernd

Contact us

Opnunartímar hjartaverndar

Opening hours

  • Mon - Fri: 08:00-16:00
  • Saturday and Sunday: Cloesd